Progress in the Application of Organoids-On-A-Chip in Diseases

With the rapid development of the field of life sciences, traditional 2D cell culture and animal models have long been unable to meet the urgent needs of modern biomedical research and new drug development. Establishing a new generation of experimental models and research models is of great signific...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiao Geng, Yanyan Xu, Yang Hu, Lu Wang, Yi Wang, Zhimin Fan, Desong Kong
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Organogenesis
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15476278.2024.2386727
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846119874140569600
author Qiao Geng
Yanyan Xu
Yang Hu
Lu Wang
Yi Wang
Zhimin Fan
Desong Kong
author_facet Qiao Geng
Yanyan Xu
Yang Hu
Lu Wang
Yi Wang
Zhimin Fan
Desong Kong
author_sort Qiao Geng
collection DOAJ
description With the rapid development of the field of life sciences, traditional 2D cell culture and animal models have long been unable to meet the urgent needs of modern biomedical research and new drug development. Establishing a new generation of experimental models and research models is of great significance for deeply understanding human health and disease processes, and developing effective treatment measures. As is well known, long research and development cycles, high risks, and high costs are the “three mountains” facing the development of new drugs today. Organoids and organ-on-chips technology can highly simulate and reproduce the human physiological environment and complex reactions in vitro, greatly improving the accuracy of drug clinical efficacy prediction, reducing drug development costs, and avoiding the defects of drug testing animal models. Therefore, organ-on-chips have enormous potential in medical diagnosis and treatment.
format Article
id doaj-art-d8c99d0494e64d79a3676cbe29bfb02c
institution Kabale University
issn 1547-6278
1555-8592
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Organogenesis
spelling doaj-art-d8c99d0494e64d79a3676cbe29bfb02c2024-12-16T16:20:17ZengTaylor & Francis GroupOrganogenesis1547-62781555-85922024-12-0120110.1080/15476278.2024.2386727Progress in the Application of Organoids-On-A-Chip in DiseasesQiao Geng0Yanyan Xu1Yang Hu2Lu Wang3Yi Wang4Zhimin Fan5Desong Kong6Chinese Medicine Modernization and Big Data Research Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Anoenterology, Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaChinese Medicine Modernization and Big Data Research Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of colorectal surgery, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of colorectal surgery, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of colorectal surgery, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaChinese Medicine Modernization and Big Data Research Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaWith the rapid development of the field of life sciences, traditional 2D cell culture and animal models have long been unable to meet the urgent needs of modern biomedical research and new drug development. Establishing a new generation of experimental models and research models is of great significance for deeply understanding human health and disease processes, and developing effective treatment measures. As is well known, long research and development cycles, high risks, and high costs are the “three mountains” facing the development of new drugs today. Organoids and organ-on-chips technology can highly simulate and reproduce the human physiological environment and complex reactions in vitro, greatly improving the accuracy of drug clinical efficacy prediction, reducing drug development costs, and avoiding the defects of drug testing animal models. Therefore, organ-on-chips have enormous potential in medical diagnosis and treatment.https://www.tandfonline.com/doi/10.1080/15476278.2024.2386727Disease modelmicrofluidicslorgan-on-a-chiporganoid
spellingShingle Qiao Geng
Yanyan Xu
Yang Hu
Lu Wang
Yi Wang
Zhimin Fan
Desong Kong
Progress in the Application of Organoids-On-A-Chip in Diseases
Organogenesis
Disease model
microfluidics
lorgan-on-a-chip
organoid
title Progress in the Application of Organoids-On-A-Chip in Diseases
title_full Progress in the Application of Organoids-On-A-Chip in Diseases
title_fullStr Progress in the Application of Organoids-On-A-Chip in Diseases
title_full_unstemmed Progress in the Application of Organoids-On-A-Chip in Diseases
title_short Progress in the Application of Organoids-On-A-Chip in Diseases
title_sort progress in the application of organoids on a chip in diseases
topic Disease model
microfluidics
lorgan-on-a-chip
organoid
url https://www.tandfonline.com/doi/10.1080/15476278.2024.2386727
work_keys_str_mv AT qiaogeng progressintheapplicationoforganoidsonachipindiseases
AT yanyanxu progressintheapplicationoforganoidsonachipindiseases
AT yanghu progressintheapplicationoforganoidsonachipindiseases
AT luwang progressintheapplicationoforganoidsonachipindiseases
AT yiwang progressintheapplicationoforganoidsonachipindiseases
AT zhiminfan progressintheapplicationoforganoidsonachipindiseases
AT desongkong progressintheapplicationoforganoidsonachipindiseases